Delivery Order SPE2DB20D9331-SPE2DB22FL0K3
- Not listed
- This federal contract award, valued at $43,220.28, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for 4,559,233,967 units of the oncology medication Oncaspar (pegaspargase) in 5 mL vials. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,531.40 firm fixed-price delivery order is for the supply of 4,560 units of the injectable oncology medication Oncaspar (pegaspargase) in 5 mL vials. The delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $65,086.14 firm fixed-price delivery order covers the provision of 4,558,704,484 units of the injectable chemotherapy medication Oncaspar (pegaspargase) in 5 mL vials. The delivery order falls under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $43,220.28 firm fixed-price delivery order is for the supply of 4,556,804,056 units of the oncology medication ONCASPAR (pegaspargase) in 5 mL vials. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, which allows the DLA to issue...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of 3,750 units of the drug Oncaspar (pegaspargase) in 5 mL vials. The contract, valued at $43,220.28, is a firm fixed-price delivery order placed by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- This federal contract award, valued at $82,930.72, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,555,565,043 units of the oncology drug ONCASPAR in 5 ml vials. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,531.40 firm fixed-price delivery order is for the supply of 4,566,744,841 units of the oncology medication ONCASPAR 3,750 UNIT/5 ML VIAL 5ML. This award is made under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to issue...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $86,440.56 firm fixed-price delivery order is for the supply of ONCASPAR 3,750 UNIT/5 ML VIAL 5ML, a pharmaceutical product, to support the medical supply needs of Department of Defense (DoD) healthcare facilities. The award is part of a larger indefinite delivery contract (IDC) valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $82,930.72 delivery order is for 3,750 units of the oncology medication ONCASPAR in 5 ML vials. The award is under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 between DMS Pharmaceutical Group and the DLA, which enables the DLA to issue delivery orders for a comprehensive...
- This federal contract award, valued at $86,440.56, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4,557,549,804 units of the oncology medication ONCASPAR in 5 ML vials. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB22FL0K3Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $43,220.28, is a firm fixed-price delivery order for the supply of 4,556,239,764 units of the oncology drug Oncaspar (pegaspargase) in 5 ml vials. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. As a woman-owned small business, DMS Pharmaceutical Group is able to secure direct awards for pharmaceutical Prime Vendor programs supporting the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.2k | 1/11/22 |